Literature DB >> 34205794

Hemoglobin A1c in Patients with Diabetes Predict Long-Term Mortality Following Coronary Artery Surgery.

Muhammad Abu Tailakh1,2, Shlomo-Yaron Ishay3,4, Jenan Awesat4,5, Liat Poupko4,6, Gidon Sahar3,4, Victor Novack4,5,7.   

Abstract

OBJECTIVE: to estimate the association between preoperative hemoglobin A1c (HbA1c) levels below and above 7%, and the rate of all-cause mortality (ACM) in diabetes mellitus (DM) patients after coronary artery bypass grafting (CABG) within a ten-year follow-up period.
METHODS: we collected data on patient HbA1c levels that were measured up to 3 months prior to isolated CABG in consecutive patients with DM, and analyzed the rates of ACM over a median of a 5.9-year post-operative period.
RESULTS: preoperative HbA1c levels were collected in 579 DM patients. The mean HbA1c was 8.0 ± 1.7%, where 206 (35.6%) patients had an HbA1c ≤ 7% and 373 (64.4%) had an HbA1c > 7%. During the follow-up period, mortality rates were 20.4% and 28.7% in the HbA1c ≤ 7% and HbA1c > 7% groups, respectively (Kaplan-Meier estimates, log-rank p = 0.01). Multivariable Cox proportional hazards regression, adjusted for age, gender, smoking status, chronic obstructive pulmonary disease, hypertension, chronic renal failure, old myocardial infarction, number of coronary artery bypass surgeries, and post-operative glycemic control, showed a hazard ratio of 2.67 for long-term ACM (p = 0.001) in patients with HbA1c > 7%.
CONCLUSIONS: DM patients with high HbA1c levels prior to CABG are at higher risk for long-term complications, especially late ACM.

Entities:  

Keywords:  coronary artery bypass grafting; diabetes mellitus; hemoglobin A1c; mortality

Year:  2021        PMID: 34205794     DOI: 10.3390/jcm10122739

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  1 in total

1.  Health Behavior, Level of Hemoglobin A1c, and Quality of Life Among Agricultural Workers of Various Ethnicities in Thai Border Communities.

Authors:  Sorawit Boonyathee; Parichat Ong-Artborirak; Katekaew Seangpraw; Prakasit Tonchoy; Supakan Kantow; Sasivimol Bootsikeaw; Nisarat Auttama; Monchanok Choowanthanapakorn; Dech Dokpuang; Pitakpong Panta
Journal:  Front Med (Lausanne)       Date:  2022-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.